IMARC Group, a leading market research company, has recently releases report titled “Nutrigenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”The global nutrigenomics market size reached US$ 1,083 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,278 Million by 2028, exhibiting a growth rate (CAGR) of 12% during 2023-2028.
What is Nutrigenomics Market?
Nutrigenomics, also called nutritional genomics, represents a subset of medical science that analyzes the relationship between nutrition and the human genome. It usually focuses on understanding the correlation between genes and diet and their effect on human health and the risk of developing diseases, such as cardiovascular diseases (CVDs), obesity, cancer, etc.
Nutrigenomics helps in detecting factors of aging as well as disease predisposition and creating personalized diet or nutrition plans depending on genotype. It also aids in understanding the toxicity and safety profile of macro- and micronutrients and preventing diet-associated diseases. Furthermore, nutrigenomics testing is generally done by taking samples of buccal swabs, blood, saliva, etc.
Request a free sample brochure: https://www.imarcgroup.com/nutrigenomics-market/requestsample
Nutrigenomics Market Trends and Drivers:
The growing prevalence of obesity is primarily driving the nutrigenomics market. Additionally, the rising consumer inclination towards health and fitness and the escalating demand for personalized nutrition products, especially among fitness enthusiasts and athletes, are further catalyzing the market growth. Besides this, the increasing investments in R&D activities to introduce potential cures and innovative medicine using human genetics as a basis for discovery are acting as significant growth-inducing factors.
Moreover, they are focusing on developing tailor-made food to match a particular gene profile, such as decreasing the intake of cholesterol compounds and strengthening the weak immune system, which is acting as another significant growth-inducing factor. Apart from this, the elevating incidences of nutritional deficiency disorders, including lack of folate, iron anemia, vitamins D and K, hypocalcemia, osteomalacia, xerophthalmia, scurvy, pellagra, rickets, etc., are anticipated to fuel the nutrigenomics market over the forecasted period.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- BASF SE
- Cell-Logic
- Cura Integrative Medicine
- Danone S.A, Fagron
- Genova Diagnostics
- Holistic Health International
- Koninklijke DSM N.V.
- Metagenics Inc.
- Nutrigenomix Inc.
- Xcode Life.
Nutrigenomics Market Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Product:
- Reagents and Kits
- Services
Breakup by Sample Type:
- Saliva
- Buccal Swab
- Blood
- Others
Breakup by Application:
- Cardiovascular Diseases
- Obesity
- Cancer Research
- Others
Breakup by End User:
- Dieticians
- Sport Clinics
- Corporate Programs
- Others
By Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/